Windlas Biotech Limited (NSE:WINDLAS)
971.00
+14.80 (1.55%)
May 22, 2025, 3:29 PM IST
Windlas Biotech Company Description
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally.
The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms.
It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids.
Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.
Windlas Biotech Limited
Country | India |
Founded | 2001 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,154 |
CEO | Komal Gupta |
Contact Details
Address: 705-706, Vatika Professional Point Gurugram, Haryana 122001 India | |
Phone | 91 12 4282 1030 |
Website | windlas.com |
Stock Details
Ticker Symbol | WINDLAS |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE0H5O01029 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Komal Gupta | Chief Financial Officer and Chief Executive Officer |
Ananta Narayan Panda | Company Secretary and Compliance Officer |
Ashok Kumar Windlass | Whole-Time Director |
Hitesh Windlass | MD and Executive Director |
Manoj Kumar Windlass | Joint MD and Executive Director |
Pawan Kumar Sharma | Executive Director |
Mohammed Aslam | President of Sales and Marketing |
Om Prakash Sule | Site Quality Head |